1.McDonald, LC, Killgore, GE, Thompson, A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353(23): 2433–2441.
2.Loo, VG, Poirier, L, Miller, MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353(23):2442–2449.
3.Pépin, J, Valiquette, L, Alary, ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171(5):466–472.
4.Eaton, L. C difficile cases rising, but MRSA rates falling. BMJ 2007;335(7612):177.
5.Archibald, LK, Banerjee, SN, Jarvis, WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004;189(9):1585–1589.
6.Dallal, RM, Harbrecht, BG, Boujoukas, AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and com-plications. Ann Surg 2002;235(3):363–372.
7.Muto, CA, Pokrywka, M, Shutt, K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26(3):273–280.
8.McEllistrem, MC, Carman, RJ, Gerding, DN, Genheimer, CW, Zheng, L. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis 2005;40(2):265–272.
9.Centers for Disease Control and Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk—four states, 2005. MMWR Morb Mortal Wkly Rep 2005;54(47):1201–1205.
10.Dial, S, Delaney, JA, Barkun, AN, Suissa, S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294(23):2989–2995.
11.McDonald, LC, Coignard, B, Dubberke, E, Song, X, Horan, T, Kutty, PK; Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28(2):140–145.
12.Buehler, JW. Review of the 2003 National Syndromic Surveillance Conference—lessons learned and questions to be answered. MMWR Morb Mortal Wkly Rep 2004;53(suppl):18–22.
13.Mandl, KD, Overhage, JM, Wagner, MM, et al. Implementing syndromic surveillance: a practical guide informed by the early experience. J Am Med Inform Assoc 2004;11(2);141–150.
14.Centers for Disease Control and Prevention. Automated detection and reporting of notifiable diseases using electronic medical records versus passive surveillance?—Massachusetts, June 2006-July 2007. MMWR 2008;57(14):373–376.
15.Loonsk, JW. BioSense—a national initiative for early detection and quantification of public health emergencies. MMWR Morb Mortal Wkly Rep 2004;53(suppl):53–55.
16.Bradley, CA, Rolka, H, Walker, D, Loonsk, J. BioSense: implementation of a National Early Event Detection and Situational Awareness System. MMWR Morb Mortal Wkly Rep 2005;26:54(suppl):11–19.
17.Kutty, PK, Benoit, SR, Woods, CW, et al. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol 2008;29(3): 197–202.
18.Dubberke, ER, Butler, AM, Hota, B, et al; Prevention Epicenters Program from the Centers for Disease Control and Prevention. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol 2009;30(6):518–525.
19.Sohn, S, Climo, M, Diekema, D, et al; Prevention Epicenter Hospitals. Varying rates of Clostridium difficile-associated diarrhea at prevention epicenter hospitals. Infect Control Hosp Epidemiol 2005;26(8):676–679.
20.Campbell, RJ, Giljahn, L, Machesky, K, et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 2009;30(6):526–533.
21.Chang, HT, Krezolek, D, Johnson, S, Parada, JP, Evans, CT, Gerding, DN. Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital. Infect Control Hosp Epidemiol 2007;28(8):926–931.
22.Effler, P, Ching-Lee, M, Bogard, A, Ieong, MC, Nekomoto, T, Jernigan, D. Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. JAMA 1999;282(19):1845–1850.
23.Panackal, AA, M'ikanatha, NM, Tsui, FC, et al. Automatic electronic laboratory-based reporting of notifiable infectious diseases at a large health system. Emerg Infect Dis 2002;8(7):685–691.
24.Overhage, JM, Grannis, S, McDonald, CJ. A comparison of the completeness and timeliness of automated electronic laboratory reporting and spontaneous reporting of notifiable conditions. Am J Public Health 2008;98(2):344–350.
25.Tabak, YP, Sievert, DM, Zilberberg, MD, et al. The epidemiology of initial and recurrent Clostridium difficile infections in US hospitals, 2007-2008. In: Program and abstracts of the 47th Annual Meeting of the Infectious Diseases Society of America. Philadephia, PA; 2009. Abstract 179.
27. Office of the National Coordinator for Health Information Technology Website, http://www.healthit.hhs.gov. Accessed March 10, 2010.
28.Dubberke, ER, Reske, KA, McDonald, LC, Fraser, VJ. ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis 2006;12(10):1576–1579.
29.Dubberke, ER, Butler, AM, Yokoe, DS, et al; Prevention Epicenters Program of the Centers for Disease Control and Prevention. Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol 2010;31(3):262–268.